![](/coreweb/template1/pix/main_left_bg.gif) |
![](/coreweb/template1/pix/pixel.gif) |
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Feb 15, 2024 |
Title |
B-cell Intrinsic Regulation of Antibody Mediated Immunity by Histone H2A Deubiquitinase BAP1 [ChIP-seq] |
Organism |
Mus musculus |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
BAP1 is a deubiquitinase (DUB) of the Ubiquitin C-terminal Hydrolase (UCH) family that regulates gene expression and other cellular processes, through its direct catalytic activity on the repressive epigenetic mark histone H2AK119ub, as well as several other substrates. BAP1 is also a highly important tumor suppressor, expressed and functional across many cell types and tissues. In recent work, we demonstrated a cell intrinsic role of BAP1 in the B cell lineage development in murine bone marrow, however the role of BAP1 in the regulation of B cell mediated humoral immune response has not been previously explored. In the current study, we demonstrate that a B-cell intrinsic loss of BAP1 function in activated B cells in the Bap1fl/fl Cγ1-cre murine model results in a severe defect in antibody production, with altered dynamics of germinal centre B cell, memory B cell, and plasma cell numbers. At the cellular and molecular level, BAP1 was dispensable for B cell immunoglobulin class switching but resulted in an impaired proliferation of activated B cells, with genome-wide dysregulation in histone H2AK119ub levels and gene expression. In summary, our study establishes the B-cell intrinsic role of BAP1 in antibody mediated immune response and indicates its central role in the regulation of the genome-wide landscapes of histone H2AK119ub and downstream transcriptional programs of B cell activation and humoral immunity.
|
|
|
Overall design |
To identify the genomic regions directly regulated by BAP1 in activated B cells, we conducted ChIP-seq to map the BAP1 genome-wide DNA-binding sites in CH12F3 cells, firstly using wild type cells with an anti-BAP1 antibody, repeating the analyses with both untreated cells and cells at 72 hours of stimulation with TGF-β, IL-4, and anti-CD40, corresponding to the standard protocol for CH12F3 cell activation. ChIP-seq analysis was further repeated using the CH12F3 cells stably expressing 3xFLAG-tagged BAP1 with an antibody against the FLAG epitope.
|
|
|
Contributor(s) |
Liang Y, Wang H, Seija N, Lin YH, Tung LT, Di Noia JM, Langlais D, Nijnik A |
Citation(s) |
38529289 |
|
Submission date |
Oct 12, 2023 |
Last update date |
Apr 05, 2024 |
Contact name |
Anastasia Nijnik |
E-mail(s) |
anastasia.nijnik@mcgill.ca
|
Phone |
514-398-5567
|
Organization name |
McGill University
|
Department |
Physiology
|
Lab |
Nijnik Lab
|
Street address |
Rm 368 - 3649 Promenade Sir William Osler
|
City |
Montreal |
State/province |
Quebec |
ZIP/Postal code |
H3G 0B1 |
Country |
Canada |
|
|
Platforms (1) |
GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
Samples (20)
|
|
Relations |
BioProject |
PRJNA1027438 |
Supplementary file |
Size |
Download |
File type/resource |
GSE245220_RAW.tar |
17.0 Gb |
(http)(custom) |
TAR (of BW) |
SRA Run Selector![Help](/coreweb/images/long_help4.gif) |
Raw data are available in SRA |
|
|
|
|
![](/coreweb/template1/pix/main_right_bg.gif) |